Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Capstone Holding Corp. Director's Dealing 2013

Jan 30, 2013

35323_dirs_2013-01-29_5bc684a7-7637-426f-9584-b55557f0864a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2013-01-25

Reporting Person: MILLER LLOYD I III (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-01-25 Common Stock J 362050 $0.00 Acquired 724100 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 472792 Indirect
Common Stock 90344 Indirect
Common Stock 641218 Indirect
Common Stock 4412468 Indirect
Common Stock 58967 Direct

Footnotes

F1: As a result of liquidating distributions of various assets to other members of the LLC, the reporting person's pecuniary interest in shares of the issuer has increased by 362,050 shares.

F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.

F3: Milfam NG LLC changed its legal entity name to LIMFAM LLC.